Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by woundedknee on Mar 21, 2023 2:16pm

just checking

I wade in to this board from time to time just to see how my 120 grand loss is doing. I see ATE is spending about 1.4 million a month. Dan's compensation must have increased..the shares aren't worth too much right now. I see Mugsy and a couple others are still "holding the bag". Good for you. Perhaps you're waiting for another fireside chat to cheer you up. lol  Gl anyway.
Comment by MrMugsy on Mar 23, 2023 2:05pm
No fireside chat needed. We have all the information we need - for now. Acute, Chronic and IBD are all in the funnel now. So is the Antiviral but it isn't obvious ... yet. $1.4 MM has been the monthly spend and it's exactly where it should be - to grow the funnel without breaking the bank.  making anywhere from 1 to 4 points on the cash in the bank and we see other ways to cash too.  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities